Home Interaction Checker Select compound... 5-Amino-1MQ 9-Me-BC Abaloparatide ACE-031 Adalank Adamax Adipotide AHK-Cu AICAR Anadrol Anastrozole AOD-9604 Ara 290 B7-33 BAM-15 Berberine Boldenone BPC-157 Bromantane Bronchogen Cabergoline Cagrilintide Cardarine Cardiogen Cartalax Cerebrolysin Chonluten CJC-1295 (without DAC) CJC-1295 with DAC CJC/IPA Protocol Clascoterone Clenbuterol Cortagen Crystagen Cyclic Glycine-Proline Dapoxetine DHB Dianabol Dihexa DNSP-11 Doxepin DSIP Dutasteride Ecdysterone Enclomiphene Epitalon Erythropoietin (EPO) Exemestane Ezetimibe FGL Finasteride FOXO4-DRI GHK-Cu GHRP-2 GHRP-6 Glow Protocol Glutathione Gonadorelin Halotestin HCG Hexarelin HGH HGH Fragment 176-191 HMG Humanin IGF-1 DES IGF-1 LR3 IllumiNeuro Protocol Ipamorelin Ketoconazole Kisspeptin KLOW Protocol KPV L-Carnitine Letrozole LGD-4033 Liothyronine (T3) Livagen LL-37 Masteron Mazdutide Melanotan I Melanotan II Meldonium MENT Metformin Methylene Blue MGF Minoxidil MK-2866 MK-677 Modafinil MOTS-c NA Semax Amidate NA-Selank Amidate NAD+ Naltrexone Nandrolone NMN Noopept Ondansetron Orforglipron Ovagen Oxandrolone Oxiracetam Oxytocin P21 Pancragen PE-22-28 PEG-MGF Phenibut Phenylpiracetam Pinealon Pitavastatin PNC-27 PP405 Pramipexole Primobolan Propranolol Prostamax Proviron PT-141 RAD-140 Raloxifene Rapamycin Retatrutide Rosuvastatin RU-58841 Selank Semaglutide Semax Sermorelin Sildenafil SLU-PP-332 SNAP-8 SR-9009 SS-31 Superdrol Survodutide Tadalafil Tamoxifen TB-500 TB-500 (Ac-LKKTETQ) Telmisartan Teriparatide Tesa/IPA Protocol Tesamorelin Testagen Testosterone Thymalin Thymogen Thymosin Alpha 1 Thymosin Beta-4 Thymulin Tirzepatide Trazodone Trenbolone Tretinoin Tri-Heal Max Protocol Turinabol Vesilute Vesugen Vilon VIP Winstrol Wolverine Stack YK-11 Select compound... 5-Amino-1MQ 9-Me-BC Abaloparatide ACE-031 Adalank Adamax Adipotide AHK-Cu AICAR Anadrol Anastrozole AOD-9604 Ara 290 B7-33 BAM-15 Berberine Boldenone BPC-157 Bromantane Bronchogen Cabergoline Cagrilintide Cardarine Cardiogen Cartalax Cerebrolysin Chonluten CJC-1295 (without DAC) CJC-1295 with DAC CJC/IPA Protocol Clascoterone Clenbuterol Cortagen Crystagen Cyclic Glycine-Proline Dapoxetine DHB Dianabol Dihexa DNSP-11 Doxepin DSIP Dutasteride Ecdysterone Enclomiphene Epitalon Erythropoietin (EPO) Exemestane Ezetimibe FGL Finasteride FOXO4-DRI GHK-Cu GHRP-2 GHRP-6 Glow Protocol Glutathione Gonadorelin Halotestin HCG Hexarelin HGH HGH Fragment 176-191 HMG Humanin IGF-1 DES IGF-1 LR3 IllumiNeuro Protocol Ipamorelin Ketoconazole Kisspeptin KLOW Protocol KPV L-Carnitine Letrozole LGD-4033 Liothyronine (T3) Livagen LL-37 Masteron Mazdutide Melanotan I Melanotan II Meldonium MENT Metformin Methylene Blue MGF Minoxidil MK-2866 MK-677 Modafinil MOTS-c NA Semax Amidate NA-Selank Amidate NAD+ Naltrexone Nandrolone NMN Noopept Ondansetron Orforglipron Ovagen Oxandrolone Oxiracetam Oxytocin P21 Pancragen PE-22-28 PEG-MGF Phenibut Phenylpiracetam Pinealon Pitavastatin PNC-27 PP405 Pramipexole Primobolan Propranolol Prostamax Proviron PT-141 RAD-140 Raloxifene Rapamycin Retatrutide Rosuvastatin RU-58841 Selank Semaglutide Semax Sermorelin Sildenafil SLU-PP-332 SNAP-8 SR-9009 SS-31 Superdrol Survodutide Tadalafil Tamoxifen TB-500 TB-500 (Ac-LKKTETQ) Telmisartan Teriparatide Tesa/IPA Protocol Tesamorelin Testagen Testosterone Thymalin Thymogen Thymosin Alpha 1 Thymosin Beta-4 Thymulin Tirzepatide Trazodone Trenbolone Tretinoin Tri-Heal Max Protocol Turinabol Vesilute Vesugen Vilon VIP Winstrol Wolverine Stack YK-11 Add compound This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended. Shared Safety Flags 2x 2 compounds share the carcinogenic-risk safety flag (Cardarine, Testosterone). Monitor accordingly.
2x 2 HPTA-suppressive compounds (Cardarine, Testosterone). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Cardarine, Testosterone). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Cardarine, Testosterone). Monitor accordingly.
Cardarine is fully compatible with exogenous testosterone. It does not interfere with androgen receptor signaling, does not affect testosterone metabolism, and does not contribute to HPG axis suppression. The lipid-improving properties of Cardarine may partially offset the negative lipid effects of exogenous testosterone use.
Interaction data is compiled from research literature, pharmacological analysis, and community reports.
Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes.
Always consult a healthcare professional before combining compounds.